The effect of haemophilia and von willebrand disease on arterial thrombosis: A systematic review

Netherlands Journal of Medicine

Volumn 68, Issue 5, 2010, Pages 207-214

  Biere Rafi, S ^a   Zwiers, M ^b   Peters, M ^c   van der Meer, J ^b   Rosendaal, F R ^d   Buller H R ^a   Kamphuisen, P W ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c EMMA CHILDREN S HOSPITAL   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Arterial thrombosis; Atherosclerosis; Flow mediated dilatation; Haemophilia; Intima media thickness; Von willebrand disease

Indexed keywords

ARTERIAL WALL THICKNESS; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTERY THROMBOSIS; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FEMORAL ARTERY; HEMOPHILIA; HUMAN; ISCHEMIC HEART DISEASE; MEDLINE; PROTECTION; RISK REDUCTION; STANDARDIZED MORTALITY RATIO; SYSTEMATIC REVIEW; VON WILLEBRAND DISEASE; ARTERIAL OCCLUSIVE DISEASES; HEART MUSCLE ISCHEMIA; HEMOPHILIA A; MORTALITY; THROMBOSIS; VON WILLEBRAND DISEASES;

ARTERIAL OCCLUSIVE DISEASES; ATHEROSCLEROSIS; HEMOPHILIA A; HUMANS; MYOCARDIAL ISCHEMIA; THROMBOSIS; VON WILLEBRAND DISEASES;

EID: 77953303993     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Kannel WB. Overview of hemostatic factors involved in atherosclerotic cardiovascular disease. Lipids. 2005;40:1215-1220.
2. Meade TW, Cooper JA, Howarth DJ, Ruddock V, Miller GJ. Factor VIII and ABO blood group and the incidence of ischaemic heart disease. Br J Haematol. 1994;88;601-607.
3. Spiel AO, Gilbert JC, Jilma B. Von Willebrand factor in cardiovascular disease. Focus on acute coronary syndromes. Circulation. 2008;117;1449-1459.
4. Rosendaal FR, Varekamp I, Smith C, et al. Mortality and causes of death in Dutch haemophiliacs. Br J Haematol. 1989;71:71-76.
5. Darby SC, Kan SW, Spooner RJ, et al. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood. 2007;110:815-825.
6. Bilora F, Boccioletti V, Zanon E, Petrobelli F, Girolami A. Hemophilia A, von Willebrand disease, and atherosclerosis of abdominal aorta and leg arteries:factor VIII and von Willebrand factor defects appear to protect abdominal aorta and leg arteries from atherosclerosis. Clin Appl Thromb Hemost. 2001;7:311-313.
7. Sramek A, Bucciarelli P, Federici AB, et al. Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis. Results from a multicenter study in 47 patients. Circulation. 2004;109:740-744.
8. Ferderici AB, Mannucci PM, Fogato E, Ghidoni P, Matturri L. Autopsy findings in three patients with von Willebrand disease type IIB and type III: presence of atherosclerotic lesions without occlusive arterial thrombi. Thromb Haemost. 1993;70:758-761.
9. Kernoff LM, Rose AG, Hughes J, Jacobs P. Autopsy findings in an elderly man suffering from severe von Willebrand's disease. Thromb Haemost. 1981;46:714-716.
10. Goodnough LT, Saito H, Ratnoff OS. Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: A report of 21 patients and a review of 50 previously reported cases. Medicine. 1983;62:248-255.
11. Silwer J, Cronberg S, Nilsson IM. Occurrence of arteriosclerosis in von Willebrand's disease. Acta Medica Scandinavica. 1966;180:475-484.
12. Small M, Jack AS, Mutch AF, Forbes CD, Prentice CR. Coronary artery disease in severe haemophilia. Heart. 1983;49:604-607.
13. Girolami A, Ruzzon E, Fabris F, et al. Myocardial infarction and other arterial occlusions in hemophilia A patients. A cardiological evaluation of all 42 cases reported in the literature. Acta Haematol. 2006;116:120-125.
14. Girolami A, Randi ML, Ruzzon E, Varvarikis C, Sartori R, Girolami B. Myocardial infarction, other arterial thrombosis and invasive coronary procedures in haemophilia B: A critical evaluation of reported cases. J Thromb Thrombolysis. 2005;20:43-46.
15. Girolami A, Tezza F, Scapin M, Vettore S, Casonato A. Arterial and venous thrombosis in patients with von Willebrand's disease: A critical review of the literature. J Thromb Thrombolysis. 2006;21:175-178.
16. Tuinenburg A, Mauser-Bunschoten EP, Verhaar MC, Biesma DH, Schutgens RE. Cardiovascular disease in patients with hemophilia. J Thromb Haemost. 2009;7:247-254.
17. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-2012.
18. Sramek A, Reiber JHC, Gerrits WBJ, Rosendaal FR. Decreased coagulability has no clinically relevant effect on atherogenesis: observations in individuals with a hereditary bleeding tendency. Circulation. 2001;104:762-767.
19. Sartori MT, Bilora F, Zanon E, et al. Endothelial dysfunction in haemophilia patients. Haemophilia. 2008;14:1055-1062.
20. Bilora F, Rossi CD, Casonato A, et al. Do hemophilia A and von Willebrand disease protect against carotid atherosclerosis? A comparative study between coagulopathics and normal subjects by means of carotid echo-color Doppler scan. Clin Appl Thromb Hemost. 1999;5:232-235.
21. Bilora F, Zanon E, Casonato A, et al. Type IIB von Willebrand disease: role of qualitative defects in atherosclerosis and endothelial dysfunction. Clin Appl Thromb Hemost. 2007;13:384-390.
22. Triemstra M, Rosendaal FR, Smit C, Van der Ploeg HM, Briët E. Mortality in patients with hemophilia: changes in a Dutch population from 1986 to 1992 and 1973 to 1986. Ann Int Med. 1995;123:823-827.
23. Plug I, van der Bom JG, Peters M, et al. Mortality and causes of death in patients with hemophilia 1992-2001: a prospective cohort study. J Thromb Haemost. 2006;4:510-516.
24. Koumbarelis E, Rosendaal FR, Gialeraki, et al. Epidemiology of haemophilia in Greece: an overview. Thromb Haemost. 1994;72:808-813.
25. Soucie JM, Nuss R, Evatt B, et al. Mortality among males with hemophilia: relations with source of medical care. Blood. 2000;96:437-442.
26. Kulkarni R, Soucie JM, Evatt BL. Prevalence and risk factors for heart disease among males with hemophilia. Am J Hematol. 2005;79:36-42.
27. Sramek A, Kriek M, Rosendaal F. Decreased mortality of ischaemic heart disease among carriers of haemophilia. Lancet. 2003;362:351-354.
28. Walker IR, Julian JA. Causes of death in Canadians with haemophilia 1980-1995. Haemophilia. 1998;4:714-720.
29. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature. 2000;407:258-264.
30. Major CD, Santulli RJ, Derian CK, Andrade-Gordon P. Extracellular mediators in atherosclerosis and thrombosis: lessons from thrombin receptor knockout mice. Arterioscler Thromb Vasc Biol. 2003;23:931-939.
31. Camerer E. Unchecked thrombin is bad news for troubled arteries. J Clin Invest. 2007;117:1486-1489.
32. Coughlin SR, Camerer E. Participation in inflammation. J Clin Invest. 2003;111:25-27.
33. Rosendaal FR, Briet E, Stibbe J, et al. Haemophilia protects against ischaemic heart disease: a study of risk factors. Br J Haematol. 1990;75:525-553.
34. Mannucci PM, Schutgens RE, Santagostino E, Mauser-Bunschoten EP. How I treat age-related morbidities in elderly persons with hemophilia. Blood. 2009;114:5256-5263.
35. Keymel S, Kalka C, Rassaf T, Yeghiazarians Y, Kelm M, Heiss C. Impaired endothelial progenitor cell function predicts age-dependent carotid intimal thickening. Basic Res Cardiol. 2008;103:582-586.
36. Kotsis VT, Stabouli SV, Papamichael CM, Zakopoulos NA. Impact of obesity in intima media thickness of carotid arteries. Obesity. 2006;14:1708-1715.